Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126046442 | 12604644 | 2 | F | 20160706 | 20160815 | 20160728 | 20160823 | EXP | JP-009507513-1607JPN012090 | MERCK | 65.00 | YR | M | Y | 68.00000 | KG | 20160823 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126046442 | 12604644 | 1 | PS | CANCIDAS | CASPOFUNGIN ACETATE | 1 | Intravenous drip | 50 MG, QD | 350 | MG | 21227 | 50 | MG | INJECTION | QD | ||||
| 126046442 | 12604644 | 2 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | 660 MG, TID | 41580 | MG | 0 | 660 | MG | TABLET | TID | ||||
| 126046442 | 12604644 | 3 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, QD | 315 | MG | 0 | 15 | MG | TABLET | QD | ||||
| 126046442 | 12604644 | 4 | C | ADALAT CC | NIFEDIPINE | 1 | Oral | 20 MG, QD | 280 | MG | 0 | 20 | MG | TABLET | QD | ||||
| 126046442 | 12604644 | 5 | C | MYSLEE | ZOLPIDEM TARTRATE | 1 | Oral | 5 MG, QD | 105 | MG | 0 | 5 | MG | TABLET | QD | ||||
| 126046442 | 12604644 | 6 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Oral | 250 MG, QID | 3000 | MG | 0 | 250 | MG | QID | |||||
| 126046442 | 12604644 | 7 | C | GRACEVIT | SITAFLOXACIN | 1 | Oral | 50 MG, BID | 0 | 50 | MG | BID | |||||||
| 126046442 | 12604644 | 8 | C | MEROPENEM. | MEROPENEM | 1 | Parenteral | 0.5 G, TID | 15 | G | 0 | .5 | G | INJECTION | TID | ||||
| 126046442 | 12604644 | 9 | C | VANCOMYCIN | VANCOMYCIN | 1 | Parenteral | 1 G, BID | 14 | G | 0 | 1 | G | INJECTION | BID | ||||
| 126046442 | 12604644 | 10 | C | GRAN | FILGRASTIM | 1 | Parenteral | 150 MICROGRAM, QD | 1050 | UG | 0 | 150 | UG | INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126046442 | 12604644 | 1 | Febrile neutropenia |
| 126046442 | 12604644 | 2 | Constipation |
| 126046442 | 12604644 | 3 | Gastric ulcer |
| 126046442 | 12604644 | 4 | Hypertension |
| 126046442 | 12604644 | 5 | Insomnia |
| 126046442 | 12604644 | 6 | Pseudomembranous colitis |
| 126046442 | 12604644 | 7 | Bacterial infection |
| 126046442 | 12604644 | 8 | Bacterial infection |
| 126046442 | 12604644 | 9 | Bacterial infection |
| 126046442 | 12604644 | 10 | Neutropenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126046442 | 12604644 | LT |
| 126046442 | 12604644 | OT |
| 126046442 | 12604644 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126046442 | 12604644 | Acute myeloid leukaemia | |
| 126046442 | 12604644 | Pneumonia | |
| 126046442 | 12604644 | Pseudomembranous colitis | |
| 126046442 | 12604644 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126046442 | 12604644 | 1 | 20160706 | 20160712 | 0 | |
| 126046442 | 12604644 | 2 | 20160623 | 20160718 | 0 | |
| 126046442 | 12604644 | 3 | 20160623 | 20160718 | 0 | |
| 126046442 | 12604644 | 4 | 20160630 | 20160718 | 0 | |
| 126046442 | 12604644 | 5 | 20160623 | 20160718 | 0 | |
| 126046442 | 12604644 | 6 | 20160711 | 20160718 | 0 | |
| 126046442 | 12604644 | 7 | 20160713 | 20160718 | 0 | |
| 126046442 | 12604644 | 8 | 20160704 | 20160718 | 0 | |
| 126046442 | 12604644 | 9 | 20160707 | 20160718 | 0 | |
| 126046442 | 12604644 | 10 | 20160707 | 20160717 | 0 |